World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
33057
World Ranking
12576
National Ranking
170

Overview

Hans R. Brunner is affiliated with the University of Lausanne in Switzerland and has contributed to research across multiple fields, primarily focused in medicine and agricultural and biological sciences.

Their research spans a variety of subfields including endocrinology, diabetes and metabolism, plant science, surgery, soil science, and accounting. This multidisciplinary approach is reflected in their publication topics, which cover hormonal regulation and hypertension, adrenal hormones and disorders, adrenal and paraganglionic tumors, plant physiology and cultivation studies, horticultural and viticultural research, irrigation practices and water management, as well as private equity and venture capital.

Hans R. Brunner's recent papers include:

  • Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial (2024, EClinicalMedicine)
  • PS-C37-5: NEW THERAPEUTIC PERSPECTIVES FOR BLOOD PRESSURE CONTROL: DEXFADROSTAT PHOSPHATE, A NOVEL ALDOSTERONE SYNTHASE INHIBITOR, IN PATIENTS WITH PRIMARY ALDOSTERONISM (2023, Journal of Hypertension)
  • Prognosefähigkeit von Kennzahlen während der Laufzeit von Private Equity Fonds (2022, WiSt - Wirtschaftswissenschaftliches Studium)

Their work has been published in venues such as EClinicalMedicine, Journal of Hypertension, and WiSt - Wirtschaftswissenschaftliches Studium, demonstrating engagement in both medical and economic research publications.

Collaboration is a consistent feature of their research, with frequent coauthors including Paolo Mulatero, Michael Groessl, Bruno Vogt, Andreas Häseli, and Franco Weibel.

In addition to articles, Hans R. Brunner has published books with Organic Eprints, affiliated with the International Centre for Research in Organic Food Systems and the Research Institute of Organic Agriculture. Notable book titles include "Cultivarea ecologică a pomilor fructiferi cu trunchi înalt" and "Organicheskoye vyrashchivaniye vysokostvol'nykh plodovykh derev'yev," both published in 2021.

Best Publications

  • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

    Stevo Julius;Sverre E Kjeldsen;Michael Weber;Hans R Brunner

  • Essential hypertension: renin and aldosterone, heart attack and stroke

    Hans R. Brunner;John H. Laragh;Leslie Baer;Michael A. Newton

  • Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

    Bühler Fr;Laragh Jh;Baer L;Vaughan Ed

  • Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

    Michael A Weber;Stevo Julius;Sverre E Kjeldsen;Hans R Brunner

  • Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

    Haralambos Gavras;Hans R. Brunner;Gustave A. Turini;Glenn R. Kershaw

  • Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

    John H. Laragh;Leslie Baer;Hans R. Brunner;Fritz R. Buhler

  • Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100) Comparison With Enalapril

    Juerg Nussberger;Grégoire Wuerzner;Chris Jensen;Hans R. Brunner

  • Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

    Hans R. Brunner;Haralambos Gavras;Bernard Waeber;Glen R. Kershaw

  • Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

    Thierry Pedrazzini;Josiane Seydoux;Pierre Künstner;Jean-François Aubert

  • Influence of Oscillatory and Unidirectional Flow Environments on the Expression of Endothelin and Nitric Oxide Synthase in Cultured Endothelial Cells

    Thierry Ziegler;Karima Bouzourène;Vanessa J. Harrison;Hans R. Brunner

  • An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

    Haralambos Gavras;Hans R. Brunner;John H. Laragh;Jean E. Sealey

  • Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.

    Julien Rossat;Marc Maillard;Jürg Nussberger;Hans R. Brunner

  • Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements.

    Y Tardy;J J Meister;F Perret;H R Brunner

  • Antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension*

    Fritz R. Bühler;John H. Laragh;E. Darracott Vaughan;Hans R. Brunner

  • Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions

    Michel Burnier;Marie Paule Schneider;Arnaud Chiolero;Claire Lise Fallab Stubi

  • Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

    Y. Christen;B. Waeber;J. Nussberger;M. Porchet

  • ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSURE

    H.R. Brunner;H. Gavras;J.H. Laragh;R. Keenan

  • Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

    Pierre Boutouyrie;Caroline Bussy;Daniel Hayoz;Jurg Hengstler

  • Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.

    Jerôme Biollaz;Hans R. Brunner;Irène Gavras;Bernard Waeber

  • Angiotensin converting enzyme inhibition in patients with congestive heart failure.

    H Gavras;D P Faxon;J Berkoben;H R Brunner

Frequent Co-Authors

Bernard Waeber
Bernard Waeber University of Lausanne
Haralambos Gavras
Haralambos Gavras Boston University
Michel Burnier
Michel Burnier University of Lausanne
John H. Laragh
John H. Laragh Cornell University
Alberto Zanchetti
Alberto Zanchetti University of Milan
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Jean E. Sealey
Jean E. Sealey Cornell University
Michael A. Weber
Michael A. Weber SUNY Downstate Medical Center
Pascal Nicod
Pascal Nicod University Hospital of Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative healthcare career options beyond traditional medical school? There are many related degrees and pathways to explore that leverage a variety of skills and time commitments. For those who already have a non-nursing bachelor’s degree, msn direct entry programs online offer an accelerated route into nursing with flexible, online study options.

If you’re looking for quicker or more accessible ways to enter nursing, you may wonder, whats the easiest nursing program to get into? Some schools provide less competitive admissions, making it easier for aspiring healthcare professionals to begin their journey.

Not everyone in healthcare needs a clinical role. Administrative careers, such as billing and coding, are vital to medical systems and can be pursued online. Consider enrolling in accredited medical billing and coding schools with financial aid for a fast track into this important field.

Lastly, if standardized tests are a barrier, you might ask: do i need to take the teas test for lpn? Many nursing schools offer pathways that do not require TEAS or HESI exams, further expanding your career options.

Best Scientists Citing Hans R. Brunner

Trending Scientists